Search research articles
Contact Us
Filters
Showing results (211-220 of 219) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 219 results.
Oncogene
|
March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma
Belamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
International Journal of Cancer
|
November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma
Janith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
The Lancet. Microbe
|
February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence
Katherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
Tropical Medicine & International Health : TM & IH
|
July 29, 2024
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis
Yohhei Hamada, Matteo Quartagno, Farihah Malik, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
The Journal of Infection
|
January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Yangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
Microorganisms
|
April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Julia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases
|
December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
Maria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Microorganisms
|
April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
Maria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 219) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 219 results.
Oncogene
|
March 4, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma
Belamy B Cheung, Ane Kleynhans, Rituparna Mittra, et al.
International Journal of Cancer
|
November 8, 2022
Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma
Janith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.
The Lancet. Microbe
|
February 26, 2026
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence
Katherine E Gallagher, Fredrick Odiwour, Christian Bottomley, et al.
Tropical Medicine & International Health : TM & IH
|
July 29, 2024
Prevalence of non-communicable diseases among household contacts of people with tuberculosis: A systematic review and individual participant data meta-analysis
Yohhei Hamada, Matteo Quartagno, Farihah Malik, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
The Journal of Infection
|
January 26, 2025
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Yangyupei Yang, Maria Deloria Knoll, Carly Herbert, et al.
Microorganisms
|
April 3, 2021
Changes in Invasive Pneumococcal Disease Caused by <i>Streptococcus pneumoniae</i> Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Julia C Bennett, Marissa K Hetrich, Maria Garcia Quesada, et al.
The Lancet. Infectious Diseases
|
December 20, 2024
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
Maria Garcia Quesada, Meagan E Peterson, Julia C Bennett, et al.
Microorganisms
|
April 30, 2021
Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project
Maria Deloria Knoll, Julia C Bennett, Maria Garcia Quesada, et al.
Page
of 22